Sirkadiyen Ritim ve Romatolojik Hastalıklar
Özet
Sirkadiyen ritim, organizmanın fonksiyonlarını 24 saatlik periyotta düzenleyerek bağışıklık sistemi ve inflamatuar süreçler üzerinde kritik bir rol oynamaktadır. Yapılan araştırmalar, bu ritimdeki düzensizliklerin romatolojik hastalıkların patogenezi ve semptom seyri ile doğrudan ilişkili olduğunu göstermektedir. Romatoid Artrit (RA) hastalarında geceleri yetersiz kortizol salgılanması, sabah saatlerinde proinflamatuar sitokinlerin (IL-6) artmasına ve buna bağlı olarak şiddetli eklem ağrısı ile sabah tutukluğuna yol açmaktadır. Bu durum, ilaçların zamanlamasını ayarlayan kronoterapi yaklaşımını ön plana çıkarmış; gece salınımlı prednizon veya gece uygulanan Metotreksat tedavisinin semptomları ve eklem katılıklarını azaltmada daha etkili olduğu kanıtlanmıştır. Psöriatik artritte melatonin düşüklüğü göze çarparken, Ankilozan Spondilitte vertebral tutukluğun sabah ve akşam saatlerinde çift tepe noktası yaptığı saptanmıştır. Sistemik Lupus Eritematozustaki sirkadiyen bozulmanın organ disfonksiyonuna, özellikle de lupus nefritine zemin hazırladığı kabul görmektedir. Fibromiyaljide ise idrardaki melatonin atılım farklılıkları sirkadiyen düzensizliğin bir biyobelirteci olarak öne çıkmakta ve pineal bez hacmi ile hastalık semptomları arasında anlamlı ilişkiler bulunmaktadır. Sonuç olarak, krono-immünolojik veriler romatizmal hastalıkların tanı ve tedavi başarısını optimize etmek için büyük bir potansiyel barındırmaktadır.
The circadian rhythm regulates organismal functions in a 24-hour period, playing a critical role in the immune system and inflammatory processes. Research demonstrates that disruptions in this rhythm are directly associated with the pathogenesis and symptom course of rheumatologic diseases. In Rheumatoid Arthritis (RA) patients, insufficient cortisol secretion at night leads to an increase in proinflamatuar cytokines (IL-6) during morning hours, causing severe joint pain and morning stiffness. This situation highlights the chronotherapy approach, which adjusts drug timing; it has been proven that night-release prednisone or nighttime Methotrexate treatment is more effective in reducing symptoms and joint stiffness. While low melatonin characterizes psoriatic arthritis, vertebral stiffness in Ankylosing Spondylitis shows a double peak in morning and evening hours. It is accepted that circadian disruption in Systemic Lupus Erythematosus paves the way for organ dysfunction, particularly lupus nephritis. In fibromyalgia, differences in urinary melatonin excretion stand out as a biomarker of circadian dysregulation, and significant relationships exist between pineal gland volume and disease symptoms. Consequently, chrono-immunological data holds great potential for optimizing the diagnosis and treatment success of rheumatic diseases.
Referanslar
Gibbs JE, Ray DW. The role of the circadian clock in rheumatoid arthritis. Arthritis Res Ther.2013:21;15(1):205.
Cutolo M. Circadian rhythms and rheumatoid arthritis. Joint Bone Spine. 2019;86(3):327-333.
Labrecque N, Cermakian N. Circadian Clocks in the Immune System. J Biol Rhythms. 2015;30(4):277-290.
Oster H, Ray DW. Chronoimmunology: from preclinical assessments to clinical applications. Semin Immunopathol 2022;44(2):149-151.
Lange T, Luebber F, Grasshoff H, et al. The contribution of sleep to the neuroendocrine regulation of rhythms in human leukocyte traffic. Semin Immunopathol. 2022;44(2):239-254.
Pourcet B, Duez H. Circadian Control of Inflammasome Pathways: Implications for Circadian Medicine. Front Immunol. 2020:31;11:1630.
Selfridge JM, Gotoh T, Schiffhauer S, et al. Chronotherapy: Intuitive, Sound, Founded. But Not Broadly Applied. Drugs. 2016;76(16):1507-1521.
Jahanban-Esfahlan R, Mehrzadi S, Reiter RJ, et al. Melatonin in regulation of inflammatory pathways in rheumatoid arthritis and osteoarthritis: involvement of circadian clock genes. Br J Pharmacol. 2018:175:3230– 3238.
Crofford LJ, Kalogeras KT, Mastorakos G, et al. Circadian relationships between interleukin (IL)-6 and hypothalamic-pituitary-adrenal axis hormones: failure of IL-6 to cause sustained hypercortisolism in patients with early untreated rheumatoid arthritis. J Clin Endocrinol Metab. 1997;82:1279–83.
Straub RH, Cutolo M. Circadian rhythms in rheumatoid arthritis: implications for pathophysiology and therapeutic management. Arthritis Res Ther. 2007;56:399–408.
Cutolo M, Paolino S, Gotelli E. Glucocorticoids in rheumatoid arthritis still on first line: the reasons. Expert Rev Clin Immunol. 2021;17(5):417-420.
Buttgereit F, Doering G, Schaeffler A, et al. Efficacy of modified-release versus standard prednisone to reduce duration of morning stiffness of the joints in rheumatoid arthritis (CAPRA-1): a double-blind, randomised controlled trial. Lancet 2008;371:205–214.
Buttgereit F, Mehta D, Kirwan J, et al. Low-dose prednisone chronotherapy for rheumatoid arthritis: a randomised clinical trial (CAPRA-2). Ann Rheum Dis. 2013;72:204–210.
Cutolo M, Hopp M, Liebscher S, et al. Modified-release prednisone for polymyalgia rheumatica: a multicentre, randomised, active-controlled, double-blind, parallel-group study. RMD Open. 2017;3:e000426.
Miler E, Stapleton PP, Mapplebeck S, et al. Circulating interleukin-6 as a biomarker in a randomized controlled trial of modified-release prednisone vs immediate-release prednisolone, in newly diagnosed patients with giant cell arteritis. Int J Rheum Dis. 2019;22:1900–1904.
Cutolo M. Glucocorticoids and chronotherapy in rheumatoid arthritis. RMD Open. 2016;2(1).
To H, Yoshimatsu H, Tomonari M, et al. Methotrexate chronotherapy is effective against rheumatoid arthritis. Chronobiol Int. 2011;28(3):267-74.
Suzuki K, Yoshida K, Ueha T, et al. Methotrexate upregulates circadian transcriptional factors PAR bZIP to induce apoptosis on rheumatoid arthritis synovial fibroblasts. Arthritis Res Ther. 2018;20(1):55.
Torres-Ruiz J, Sulli A, Cutolo M, et al. Air travel, circadian rhythms/hormones, and autoimmunity. Clin Rev Allergy Immunol. 2017:53:117–125.
Kartha LB, Chandrashekar L, Rajappa M, et al. Serum melatonin levels in psoriasis and associated depressive symptoms. Clin Chem Lab Med. 2014:52(6):e123–e125.
Slominski AT, Hardeland R, Zmijewski MA, et al. Melatonin: a cutaneous perspective on its production, metabolism, and functions. J Invest Dermatol. 2018:138(3):490–499.
Rezzani R, Rodella LF, Favero G, et al. Attenuation of ultraviolet A-induced alterations in NIH3T3 dermal fibroblasts by melatonin. Br J Dermatol. 2014:170(2):382–391.
Spies CM, Cutolo M, Straub RH, et al. More night than day--circadian rhythms in polymyalgia rheumatica and ankylosing spondylitis. J Rheumatol. 2010;37(5):894-9.
Focan C, Alvin M, Focan-Hensard D, et al. Chronobiological aspects of spondylarthritis. Ann Rev Chronopharmac. 1988;5:17–20.
Reinberg A, Manfredi R, Kahn MF, et al. Tenoxicam chronotherapy of rheumatic diseases. Ann Rev Chronopharmac. 1990;7:293–6.
Perdiz P, Wacher N, Laredo-Sanchez F, et al. Circadian variation of human acute phase response. Arch Med Res. 1996;27:157–63.
Mohandas R, Douma LG, Scindia Y, et al. Circadian rhythms and renal pathophysiology. J Clin Invest. 2022:1;132(3):e14827 7.
Caumo W, Hidalgo MP, Souza A, et al. Melatonin is a biomarker of circadian dysregulation and is correlated with major depression and fibromyalgia symptom severity. J Pain Res. 2019: 31;12:545-556.
Úbeda-D'Ocasar E, Jiménez Díaz-Benito V, Gallego-Sendarrubias GM, et al. Pain and Cortisol in Patients with Fibromyalgia: Systematic Review and Meta-Analysis. Diagnostics (Basel). 2020:9;10(11):922.
Leon-Llamas JL, Villafaina S, Murillo-Garcia A, et al. Relationship between pineal gland, sleep and melatonin in fibromyalgia women: a magnetic resonance imaging study. Acta Neuropsychiatr. 2021:14:1-9.
